George M Jenkins

Director

George M Jenkins (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Palvella Therapeutics, Inc. (PVLA). Across 1 priced purchase filing, the average 21-session return was -23.3% from execution and -21.8% from disclosure (delay-adjusted; derived). The largest single filing was $4.0M of PVLA (26,677 sh across 7 lots, as filed), executed Sep 11.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-23.3%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-21.8%

same 1 filings, from disclosure

Filings, ttm

1 buys · 1 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.5M

shares × price, as filed

Last traded

Sep 15

Filed Sep 15

Median ADV $37.6M across their filed names

Open performance→

Volume by month

Buys $500K Sells $4.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

PVLA

Palvella Therapeutics, Inc. PVLA · 1 buy · 1 sell 2 filings

Recent filings

PVLASALE Palvella Therapeutics, Inc. View filing → $4.0M
26,677 sh across 7 lots
Exec Sep 11
Filed Sep 15 · 9:15 PM ET PVLAPURCHASE Palvella Therapeutics, Inc. View filing → $500K
4,000 sh × $125.00
Exec Feb 27
Filed Mar 2 · 8:00 AM ET